Credit Suisse’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Credit Suisse’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-182,992	Closed	-$31.6M	–	4779
2015 Q1	$31.6M	Buy	182,992 +70,551	+63%	+$10.4M	0.03%	610
2014 Q4	$12.9M	Buy	112,441 +3,030	+3%	+$367K	0.01%	1111
2014 Q3	$17.1M	Sell	109,411 -19,997	-15%	-$2.9M	0.01%	989
2014 Q2	$16M	Sell	129,408 -11,684	-8%	-$1.29M	0.01%	1079
2014 Q1	$14.6M	Buy	141,092 +43,113	+44%	+$4.41M	0.01%	1009
2013 Q4	$8.81M	Buy	97,979 +23,129	+31%	+$1.84M	0.01%	1377
2013 Q3	$5.01M	Buy	74,850 +29,822	+66%	+$2.06M	0.01%	1635
2013 Q2	$2.98M	Buy	+45,028	New	+$2.58M	﹤0.01%	1975

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Credit Suisse's SLXP Position: Q2 2015 in Review

Credit Suisse sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 182,992 shares — an estimated $31.6M sold.

Credit Suisse first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $31.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Credit Suisse reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Credit Suisse sold 182,992 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $31.6M.
Credit Suisse first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Credit Suisse's SALIX PHARMACEUTICALS LTD DEL position peaked at $31.6M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Credit Suisse's 13F filing for Q2 2015, filed 13 Aug 2015.